Navigation Links
Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial
Date:12/2/2009

survival of 33 weeks and an interim median overall survival of 41 weeks. Patient enrollment in this trial has surpassed the half-way mark.

More than 70 patients with recurrent GBM have received Cotara in the current and previous clinical studies. Localization and accumulation of the drug to the tumor have been excellent and longer-term survivors (greater than one year from the time of Cotara treatment) have been observed in all of the trials, with long-term surviving patients from early GBM clinical studies now alive more than 8.5 years after treatment with Cotara. Expected survival for patients with GBM is approximately six months from the time of disease recurrence.

Overall, Cotara has been administered to a total of more than 120 patients with brain, colon, liver or other cancers. Promising data from these studies support Cotara's ability to specifically target solid tumors and its anti-tumor activity, as well as its acceptable safety profile.

About Cotara®

Cotara is an experimental treatment for brain cancer that links a radioactive isotope to a targeted monoclonal antibody designed to bind to the DNA histone complex that is exposed by dead and dying cells found at the center of solid tumors. Cotara's targeting mechanism enables it to bind to the dying tumor cells, delivering its radioactive payload to the adjacent living tumor cells and essentially destroying the tumor from the inside out, with minimal radiation exposure to healthy tissue. Cotara is delivered using convection-enhanced delivery (CED), an NIH-developed method that targets the specific tumor site in the brain. Cotara has been granted orphan drug status and fast track designation for the treatment of glioblastoma multiforme and anaplastic astrocytoma by the U.S. Food and Drug Administration.

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
2. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
3. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
4. Peregrine Pharmaceuticals to Announce Second Quarter FY 2008 Financial Results
5. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
6. Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008
7. Peregrine Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
8. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
9. Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
10. Peregrine Pharmaceuticals to Announce Third Quarter FY 2008 Financial Results
11. Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... San Diego, California (PRWEB) July 23, 2014 ... per second in HD resolution for more than 15 minutes, ... cameras to the world of high speed imaging. “Finally, a ... any other camera we use in our everyday lives.” proclaims ... goal at Fastec has always been to demystify and simplify ...
(Date:7/23/2014)... 23, 2014 Adult stem cells ... are biological, but not magical. However, many ... treat them as if they were magical. , ... studies that constitute “stem cell tourism,” are evaluating ... to developing new regenerative medicine therapies. In reality, ...
(Date:7/22/2014)... -- The Board of Directors of BD (Becton, Dickinson and ... dividend of 54.5 cents per common share payable on September ... The indicated annual dividend rate is $2.18 per share. ... medical technology company that partners with customers and stakeholders to ... needs. Our innovative solutions are focused on improving drug delivery, ...
(Date:7/22/2014)... in water with ultrasound and they,ll spin around their ... yet knows exactly. But researchers at the National Institute ... it,s fast. At up to 150,000 revolutions per minute, ... object submerged in liquid ever reported. , The discovery ... that they could be used not only for moving ...
Breaking Biology Technology:Fastec Imaging Introduces the First High Speed Camcorder 2Fastec Imaging Introduces the First High Speed Camcorder 3The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 2The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 3The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 4The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 5NIST shows ultrasonically propelled nanorods spin dizzyingly fast 2
... Part I of this series on e-discovery, ... Civil Procedure, which require parties to address and resolve ... Without a plan of attack or a system of ... unnecessarily be placing your company at risk. This ...
... - In an effort to revive Legislative support for his ... Republican skeptics, suggesting that GOP lawmakers are paying lip service ... manufacturers, and entrepreneurs. , ,Doyle, in his most pointed remarks ... than 100,000 tons of biomass resources and would benefit from ...
... controls is clearly in the hands of people. While ... in an effort to reduce testing efforts and maximize ... people. , ,Investing in your people and culture, which ... safest bet to avoid material weaknesses and gain cost ...
Cached Biology Technology:Finding Safe Harbor in a sea of electronic discovery 2Finding Safe Harbor in a sea of electronic discovery 3Technology helps but the best way to reduce Sarbox cost is with people 2Technology helps but the best way to reduce Sarbox cost is with people 3Technology helps but the best way to reduce Sarbox cost is with people 4
(Date:7/23/2014)... million people around the world have no access to ... (WHO), 3.4 million people die from water-related diseases every ... of making a contribution to solving this problem. Working ... head of the Functional Materials Laboratory, the 23-year-old spent ... prototype. , "What makes our DrinkPure filter unique is ...
(Date:7/23/2014)... , July 23, 2014 ... threat detection, announced today it has been named in ... The Market Guide replaces Gartner,s well-known Magic Quadrant for ... categorized BioCatch as one of several vendors to deliver ... analysis will become a standard feature of at least ...
(Date:7/23/2014)... HOLE, MA -- What do mollusks, starfish, and ... marine habitat, they are all calcifiersorganisms that use ... skeletons and shells for stability and protection. , ... , published by the Marine Biological Laboratory, addresses ... composition changes worldwide. , As atmospheric carbon dioxide ...
Breaking Biology News(10 mins):ETH student develops filter for clean water around the world 2BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 2BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 3Calcification in changing oceans explored in special issue of The Biological Bulletin 2
... 2010 -- Managing diabetes in a child requires a careful ... supplies, such as needles and testing strips, adds a financial ... to be published in The Journal of Pediatrics, ... of diabetes management increases a child,s risk of being hospitalized ...
... GAINESVILLE, Fla. Habitat destruction and species extinction may ... other species, according to a paper in the journal ... In the paper to be published Thursday, UF biology professor ... studies from a wide range of systems, including data from ...
... found in southeastern waters, more than 25 percent are considered ... Fisheries and Wildlife Sciences in Virginia Tech,s College of Natural ... keynote address at the Southeastern Fishes Council annual meeting in ... meeting was "Got Water? At the Crossroads of Fish Conservation ...
Cached Biology News:New study calls for greater awareness of food supply for children with diabetes 2UF expert: Biodiversity loss correlates with increases in infectious disease 2Poor stream health imperils fish 2
FITC~Bovine Serum Albumin...
... Ambion's custom siRNA service provides the premium ... silencing research. Custom siRNAs can be readily ... base target sequence, or by providing the ... out Ambion's Silencer Validated and Silencer Pre-designed ...
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
Ready for formulation or direct injection into animals Provided in convenient 100, 250, 1000 and 10,000 nmol sizes HPLC purified, salt free, sterile filtered, and endotoxin tested ...
Biology Products: